Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

🤖 Plain-English Summary

BACKGROUND: Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. CONCLUSIONS: Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease.

🔑 Key Findings

• Whether treatment with semaglutide would mitigate these risks is unknown.
• METHODS: ), at least a 50% reduction in the eGFR from baseline, or death from kidney-related or cardiovascular causes.
• Prespecified confirmatory secondary outcomes were tested hierarchically.

🔗 Related Resources